Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Chin J Integr Med ; 19(1): 48-53, 2013 Jan.
Article in English | MEDLINE | ID: mdl-21717157

ABSTRACT

OBJECTIVE: To explore the effect of ricin temperature response gel on breast cancer and its regulatory effect on immune function in rats. METHODS: Ricin was purified by chromatography and identified by immunoblotting. The rat subcutaneously transplanted breast cancer model was established. Forty model rats with a tumor diameter of about 3.0 cm were subjected to the study. They were randomized into four groups equally: the model group and three treated groups (blank gel, ricin, ricin-gel) were administered with blank gel, ricin, and ricin temperature response gel via percutaneous intratumor injection, respectively. The tumor was isolated 10 days later for the estimation of tumor inhibition rate (TIR) by weighing, pathologic examination, and detection of tumor apoptosis-associated genes bcl-2 and bax with semiquantitative RT-PCR. Also, peripheral blood was obtained to test T-lymphocyte subsets, the killing function of lymphocytes, and the contents of tumor necrosis factor-α (TNF-α) and interleukin-2 (IL-2). The outcomes were compared between groups. RESULTS: The TIR in the ricin-gel group was 61.8%, with the pathologic examination showing extensive tumor tissue necrosis. Compared with the model group, after ricin temperature response gel treatment, bcl-2 expression was down-regulated, bax expression was up-regulated, CD4+ lymphocytes and CD4+/CD8+ ratio in peripheral blood were increased, the killing function of lymphocytes was enhanced, and the contents of TNF-α and IL-2 were elevated (P < 0.05 or P < 0.01). CONCLUSION: Intratumor injection of ricin temperature-responsive gel showed significant antitumor effect on breast cancer and could enhance the immune function in the tumor-bearing rat.


Subject(s)
Antineoplastic Agents/administration & dosage , Immunomodulation/drug effects , Mammary Neoplasms, Experimental/drug therapy , Ricin/administration & dosage , Animals , Apoptosis/drug effects , CD4-CD8 Ratio , Disease Models, Animal , Female , Gels/therapeutic use , Immunohistochemistry , Injections, Intralesional , Interleukin-2/immunology , Interleukin-2/metabolism , Mammary Neoplasms, Experimental/immunology , Mammary Neoplasms, Experimental/pathology , Random Allocation , Rats , Rats, Wistar , Sensitivity and Specificity , Temperature , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
2.
Zhong Xi Yi Jie He Xue Bao ; 7(5): 447-52, 2009 May.
Article in Chinese | MEDLINE | ID: mdl-19435559

ABSTRACT

OBJECTIVE: To explore the efficacy and feasibility of interstitial chemotherapy using thermosensitive gel-coated ricin in hepatoma H22-bearing mice. METHODS: Ricin was purified by chromatography method. The purified ricin was identified by Western blot assay and the purity was determined by high-performance liquid chromatography. BALB/c mice were inoculated subcutaneously in right flank with hepatoma H22 cells. When the tumor size reached about 1.0 cm in diameter, 40 mice were randomly divided into untreated group, thermosensitive gel group, ricin group and thermosensitive gel-coated ricin group. Mice in each group were administered different agents by percutaneous intratumoral injection, including normal saline, thermosensitive hydrogel, ricin and thermosensitive gel-coated ricin. Fifteen days after treatment, the tumors were removed to calculate inhibition rate of tumor growth. The tumor tissues were made into pathological sections to perform histopathological examination. The ultrastructure of tumor tissue was examined by electron microscope examination as well. Blood was collected to detect the hepatic and renal functions. The caspase-3 activity of tumor tissue was determined by using zymologic method with a spectrophotometer. RESULTS: After intratumoral therapy, tumor weight in the thermosensitive gel-coated ricin group was lower than that in the untreated group, with a tumor growth inhibition rate of 71.31%. No obvious hepatic or renal toxicities were detected after thermosensitive gel-coated ricin treatment. Histopathologic observation of the tumor tissue showed massive necrosis and typical apoptosis phenomena, including chromatin margination and apoptotic body. Meanwhile, thermosensitive gel-coated ricin resulted in a significant increase in the caspase-3 activity as compared with the untreated group and the ricin group (P<0.01, P<0.05). CONCLUSION: The above findings indicate that intratumoral therapy with thermosensitive gel-coated ricin has strong antitumor effect and can obviously lessen systemic toxicity, which may provide an effective and feasible method for hepatocellular carcinoma treatment.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Hydrogels , Liver Neoplasms, Experimental/drug therapy , Polyethylene Glycols/chemistry , Polyglactin 910/chemistry , Ricin/administration & dosage , Animals , Caspase 3/metabolism , Drug Carriers , Injections, Intralesional , Liver Neoplasms, Experimental/pathology , Male , Mice , Mice, Inbred BALB C
3.
Hepatobiliary Pancreat Dis Int ; 4(2): 234-8, 2005 May.
Article in English | MEDLINE | ID: mdl-15908321

ABSTRACT

BACKGROUND: Portal vein tumor thrombosis (PVTT) is a serious complication and a major metastatic way of hepatocellular carcinoma(HCC). But portal vein benign thrombosis(PVBT) always appears in patients with hepatocirrhosis, and PVTT should be differentiated from PVBT. The aim of this study was to probe the value of ultrasound-guided fine needle aspiration biopsy in differential diagnosis of PVTT. METHODS: Twenty-two HCC patients with portal vein thrombosis and 8 hepatocirrhosis patients with portal vein thrombosis were studied by ultrasound-guided fine needle aspiration biopsy. Twelve portal vein thrombosis filling portal vein embranchment of the 30 portal vein thrombosis patients were examined by 18G automatic biopsy. The positive rates of aspiration biopsy cytology and histology were calculated and compared with those of automatic biopsy. RESULTS: The positive rates of fine needle aspiration biopsy cytology and histology were 93.3% (28/30) and 90.0% (27/30), respectively. They were not different markedly from that of automatic biopsy 91.7% (11/12). In aspiration biopsy of 22 HCC patients with PVTT, HCC cellular was found in 19 portal vein thrombosis patients (86.4%) by cytology examination and in 18 portal vein thrombosis patients (81.8%) by histology examination. In total, 20 tumor thrombi were detected. The other two were diagnosed as benign thrombosis. No HCC cell and/or tissue was observed in 8 patients with hepatocirrhosis associated with portal vein thrombosis. CONCLUSIONS: Ultrasound-guided fine needle biopsy in detecting PVTT shows a high positive rate and is of diagnostic value. The positive rate is not apparently different from that of automatic biopsy. Hence the case that fails to be diagnosed by color Doppler flow imaging(CDFI) and pulsed Doppler can be detected early by ultrasound-guided fine needle aspiration biopsy.


Subject(s)
Biopsy, Needle/methods , Carcinoma, Hepatocellular/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/pathology , Venous Thrombosis/pathology , Carcinoma, Hepatocellular/diagnostic imaging , Cohort Studies , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Liver Cirrhosis/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Male , Portal Vein , Prospective Studies , Sensitivity and Specificity , Ultrasonography, Doppler , Ultrasonography, Doppler, Color , Venous Thrombosis/diagnostic imaging
5.
Zhonghua Bing Li Xue Za Zhi ; 32(1): 31-4, 2003 Feb.
Article in Chinese | MEDLINE | ID: mdl-12760800

ABSTRACT

OBJECTIVE: To investigate expression of tissue transglutaminase (tTG) protein and its role in carcinogenesis of brain tumors. METHODS: tTG protein was detected by immunohistochemical method in 62 astrocytomas, 18 oligodendrogliomas, 30 benign meningiomas, 30 pituitary adenomas and 10 normal brain tissues. RESULTS: (1) In brain tumors, tTG protein expression was heterogeneous locating in tumor and endothelial cells. (2) Immunoreactivity of tTG protein was significantly different between different grades of astrocytomas. (3) Expression intensity of tTG protein in glioma was higher than that in benign brain tumors. (4) Strong expression of tTG protein in tumor cell was obtained around the necrosis foci and apoptotic cells in astrocytomas. CONCLUSIONS: tTG protein expression contributed to tumor malignant progression in malignant brain tumors.


Subject(s)
Astrocytoma/enzymology , Brain Neoplasms/enzymology , GTP-Binding Proteins/biosynthesis , Oligodendroglioma/enzymology , Transglutaminases/biosynthesis , Adolescent , Adult , Aged , Apoptosis , Astrocytoma/pathology , Brain Neoplasms/pathology , Child , Endothelial Cells/enzymology , Female , Humans , Immunohistochemistry , Male , Middle Aged , Oligodendroglioma/pathology , Protein Glutamine gamma Glutamyltransferase 2
SELECTION OF CITATIONS
SEARCH DETAIL
...